Narcolepsy: vizsgálatok itt: Dél-Korea
6 of 6 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Where
- Seongnam, Seoul, Suwon
- Életkor
- 18 év to 70 év
- People
- 150 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT07455383 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Where
- Suwon
- Életkor
- 18 év to 70 év
- People
- 176 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT07502443 - 3. fázisTaking peopleA Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Where
- Seongnam-si, Seoul
- Életkor
- 18 év to 70 év
- People
- 150 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT07540897 - 2/3. fázisTaking peopleA Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
- Where
- Daegu
- Életkor
- 18 év to 71 év
- People
- 500 worldwide
- Run by
- Takeda
See details and how to joinNCT07646678 · EU 2025-522833-68-01 - 2. fázisTaking peopleA Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
- Where
- Junggu, Seoul, Suwon
- Életkor
- 18 év to 70 év
- People
- 88 worldwide
- Run by
- Takeda
See details and how to joinNCT06952699 · EU 2024-517711-70-01 - 2. fázisNot yet taking people in Dél-KoreaA Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
- Where
- Daegu, Seongnam-si, Seoul, Suwon
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Eisai Inc.
See details and how to joinNCT07493265